Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 50/100

Failure Rate

8.9%

4 terminated/withdrawn out of 45 trials

Success Rate

84.0%

-2.5% vs industry average

Late-Stage Pipeline

20%

9 trials in Phase 3/4

Results Transparency

5%

1 of 21 completed trials have results

Key Signals

2 recruiting1 with results

Enrollment Performance

Analytics

N/A
22(62.9%)
Phase 3
8(22.9%)
Phase 2
4(11.4%)
Phase 4
1(2.9%)
35Total
N/A(22)
Phase 3(8)
Phase 2(4)
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (45)

Showing 20 of 45 trials
NCT07497893Not ApplicableNot Yet Recruiting

FENOX Trial (Comparative Effectiveness of Fexuprazan Co-therapy in Patients Receiving Non-Vitamin K Antagonist Oral Anticoagulants)

Role: lead

NCT07496281Phase 4Not Yet Recruiting

OPTIA-AF Trial: Rhythm-Guided Antithrombotic Strategy After AF Ablation

Role: lead

NCT05716997Completed

Relationship Between Coronary Angiography Findings and Fractional Flow Reserve After Balloon Angioplasty

Role: collaborator

NCT06929897Not ApplicableNot Yet Recruiting

PVI Alone vs PVI With Posterior Wall Isolation for Pulse-Field Ablation in Persistent AF

Role: lead

NCT06889818Recruiting

Korean Joint Registry for Alzheimer's Treatment and Diagnostics (JOY-ALZ)

Role: lead

NCT05725187Enrolling By Invitation

Prospective Validation Study of AI-based Prediction Algorithm for the Prediction of Paroxysmal Atrial Fibrillation

Role: lead

NCT05865106Not ApplicableCompleted

The Efficacy and Feasibility of Smartphone-Based Speech Therapy for People with Post-Stroke Dysarthria

Role: collaborator

NCT05877950Not ApplicableNot Yet Recruiting

The Effectiveness of Smartphone-Based Speech Therapy for People with Post-Stroke Dysarthria

Role: collaborator

NCT05309642Not ApplicableCompleted

Nonalcoholic Fatty Liver Disease - Intermittent Calorie Restriction (FLICR) Study

Role: lead

NCT06051162Not ApplicableUnknown

HPI Effect in Robotic Urological Surgery on AKI

Role: lead

NCT06104033Recruiting

Practice Change With Drug-coated Balloon in Patients With multiVessel Coronary Artery Disease

Role: collaborator

NCT04994639Not ApplicableCompleted

Hypotension Prediction Effect on AKI

Role: lead

NCT05584163Not ApplicableUnknown

Pilot Study to Evaluate the Prevention and Safety of Doxorubicin-induced Cardiomyopathy Using Extracorporeal Shock Waves

Role: lead

NCT05777083Not ApplicableUnknown

A Trial for the Earlier Diagnosis of Inferior Wall STEMI Using a Six-lead Handheld EKG Recorder

Role: lead

NCT04624646Not ApplicableUnknown

Clinical Implication of Atrial Fibrillation Detection Using Wearable Device in Patients With Cryptogenic Stroke

Role: lead

NCT05029115Enrolling By Invitation

The Effect of SGLT-2 Inhibitor in Patient With Atrial Fibrillation and Diabetes Mellitus

Role: lead

NCT02630069Phase 2Unknown

CDP-choline Treatment in ATS Users

Role: lead

NCT04581720Not ApplicableCompleted

Minimum Current for Train-of-four Monitoring

Role: lead

NCT03222258Completed

Prospective Cohort Study Depending on the Use of Palliative Care for Advanced Stage of Cancer Patients

Role: collaborator

NCT02799368Phase 3Completed

Balanced Salt Solution Versus 0.9% Saline Infusion for Prevention of Contrast-induced Acute Kidney Injury (BASIC Trial)

Role: collaborator